Home
Aziyo Biologics

Aziyo Biologics Market Share Analysis for May 2026

At Elutia we’re pioneering the future of patient care. Our proprietary drug-eluting biomaterial platforms stand at the forefront of medical innovation.

Health > Health - Other

Domainaziyo.com

Year Founded2015

Employees51 - 200

Annual Revenue$25M - $50M

Aziyo Biologics

Aziyo Biologics (including company regionals)

aziyo.com

See more website traffic and engagement information

Aziyo Biologics Revenue up to May 2026 is 25M - 50M

revenue generated by Aziyo Biologics top domains

Aziyo Biologics top domains revenue over 3 years

Revenue for Aziyo Biologics top domains

aziyo.com25M - 50M

See more with Sales Intelligence

Total visits to Aziyo Biologics's top domains

Understand Aziyo Biologics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Aziyo Biologics's top domains

Analyze Aziyo Biologics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Aziyo Biologics's top domains

See how Aziyo Biologics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Aziyo Biologics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Aziyo Biologics

These are the website technologies, by industry, used by Aziyo Biologics top domains

Advertising (6)

DoubleClick

Widget (5)

Twemoji

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from Aziyo Biologics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAziyo Biologics, Inc. launches cangaroo Case Study demonstrating bioenvelope benefits for reoperative procedures.Aziyo Biologics announces publication of a cangaroo® Case Study demonstrating bioenvelope benefits for reoperative procedures.

NewsAziyo Biologics, Inc. had issues with recall of its viable bone matrix products on Jul 13th '23.Aziyo Biologics on Thursday said it issued a voluntary recall of its viable bone matrix products.

NewsAziyo Biologics, Inc. partnered with LeMaitre Vascular, Inc. on Apr 20th '23.Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops biologic products to improve compatibility between medical devices and patients, has entered into a distribution agreement with LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services.